Pharmacotherapy for posttraumatic stress disorder - Rehabilitation ...

32. Grubaugh AL, Elhai JD, Cusack KJ, Wells C, Frueh BC.
Screening for PTSD in public-sector mental health settings:
the diagnostic utility of the PTSD checklist. Depress Anxiety.
2007;24(2):124–29. [PMID:16892418]
http://dx.doi.org/10.1002/da.20226
33. Yeager DE, Magruder KM, Knapp RG , Nicholas JS, Frueh
BC. Performance characteristics of the posttraumatic stress
disorder checklist and SPAN in Veterans Affairs primary
care settings. Gen Hosp Psychiatry. 2007;29(4):294–301.
[PMID:17591505]
http://dx.doi.org/10.1016/j.genhosppsych.2007.03.004
34. Shin LM, Handwerger K. Is posttraumatic stress disorder a
stress-induced fear circuitry disorder? J Trauma Stress.
2009;22(5):409–15. [PMID:19743481]
http://dx.doi.org/10.1002/jts.20442
35. Murrough JW, Huang Y, Hu J, Henry S, Williams W, Gallezot
JD, Bailey CR, Krystal JH, Carson RE, Neumeister A.
Reduced amygdala serotonin transporter binding in posttraumatic
stress disorder. Biol Psychiatry. 2011;70(11):
1033–38. [PMID:21855859]
http://dx.doi.org/10.1016/j.biopsych.2011.07.003
36. Wessa M, Rohleder N, Kirschbaum C, Flor H. Altered cortisol
awakening response in posttraumatic stress disorder. Psychoneuroendocrinology.
2006;31(2):209–15. [PMID:16154709]
http://dx.doi.org/10.1016/j.psyneuen.2005.06.010
37. Yehuda R. Biology of posttraumatic stress disorder. J Clin
Psychiatry. 2001;62(Suppl 17):41–46. [PMID:11495096]
38. De Kloet CS, Vermetten E, Geuze E, Kavelaars A, Heijnen
CJ, Westenberg HG. Assessment of HPA-axis function in
posttraumatic stress disorder: pharmacological and nonpharmacological
challenge tests, a review. J Psychiatr Res.
2006;40(6):550–67. [PMID:16214171]
http://dx.doi.org/10.1016/j.jpsychires.2005.08.002
39. Pole N. The psychophysiology of posttraumatic stress disorder:
a meta-analysis. Psychol Bull. 2007;133(5):725–46.
[PMID:17723027]
http://dx.doi.org/10.1037/0033-2909.133.5.725
40. Marshall RD, Lewis-Fernandez R, Blanco C, Simpson HB,
Lin SH, Vermes D, Garcia W, Schneier F, Neria Y,
Sanchez-Lacay A, Liebowitz MR. A controlled trial of paroxetine
for chronic PTSD, dissociation, and interpersonal
problems in mostly minority adults. Depress Anxiety.
2007;24(2):77–84. [PMID:16892419]
http://dx.doi.org/10.1002/da.20176
41. Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B,
Sikes CR, Farfel GM. Efficacy and safety of sertraline
treatment of posttraumatic stress disorder: a randomized
controlled trial. JAMA. 2000;283(14):1837–44.
[PMID:10770145]
http://dx.doi.org/10.1001/jama.283.14.1837
42. Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I,
Ahmed S, Pedersen R, Musgnung J. Treatment of posttraumatic
stress disorder with venlafaxine extended release: a
713
JEFFREYS et al. Pharmacotherapy for PTSD
6-month randomized controlled trial. Arch Gen Psychiatry.
2006;63(10):1158–65. [PMID:17015818]
http://dx.doi.org/10.1001/archpsyc.63.10.1158
43. Davidson J, Pearlstein T, Londborg P, Brady KT, Rothbaum
B, Bell J, Maddock R, Hegel MT, Farfel G. Efficacy
of sertraline in preventing relapse of posttraumatic stress
disorder: results of a 28-week double-blind, placebo-controlled
study. Am J Psychiatry. 2001;158(12):1974–81.
[PMID:11729012]
http://dx.doi.org/10.1176/appi.ajp.158.12.1974
44. Davidson JR, Connor KM, Hertzberg MA, Weisler RH,
Wilson WH, Payne VM. Maintenance therapy with fluoxetine
in posttraumatic stress disorder: a placebo-controlled
discontinuation study. J Clin Psychopharmacol. 2005;
25(2):166–69. [PMID:15738748]
http://dx.doi.org/10.1097/01.jcp.0000155817.21467.6c
45. Martenyi F, Soldatenkova V. Fluoxetine in the acute treatment
and relapse prevention of combat-related post-traumatic
stress disorder: Analysis of the veteran group of a
placebo-controlled, randomized clinical trial. Eur Neuropsychopharmacol.
2006;16(5):340–49. [PMID:16356696]
http://dx.doi.org/10.1016/j.euroneuro.2005.10.007
46. Seedat S, Stein DJ, Emsley RA. Open trial of citalopram in
adults with post-traumatic stress disorder. Int J Neuropsychopharmacol.
2000;3(2):135–40. [PMID:11343590]
http://dx.doi.org/10.1017/S1461145700001899
47. Escalona R, Canive JM, Calais LA, Davidson JR. Fluvoxamine
treatment in veterans with combat-related post-traumatic
stress disorder. Depress Anxiety. 2002;15(1):29–33.
[PMID:11816050]
http://dx.doi.org/10.1002/da.1082
48. Friedman MJ, Marmar CR, Baker DG , Sikes CR, Farfel
GM. Randomized, double-blind comparison of sertraline
and placebo for posttraumatic stress disorder in a Department
of Veterans Affairs setting. J Clin Psychiatry. 2007;
68(5):711–20. [PMID:17503980]
http://dx.doi.org/10.4088/JCP.v68n0508
49. Calohan J, Peterson K, Peskind ER, Raskind MA. Prazosin
treatment of trauma nightmares and sleep disturbance in
soldiers deployed in Iraq. J Trauma Stress. 2010;23(5):
645–48. [PMID:20931662]
http://dx.doi.org/10.1002/jts.20570
50. Taylor FB, Martin P, Thompson C, Williams J, Mellman
TA, Gross C, Peskind ER, Raskind MA. Prazosin effects on
objective sleep measures and clinical symptoms in civilian
trauma posttraumatic stress disorder: a placebo-controlled
study. Biol Psychiatry. 2008;63(6):629–32.
[PMID:17868655]
http://dx.doi.org/10.1016/j.biopsych.2007.07.001
51. Raskind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA,
Warren D, Shofer J, O’Connell J, Taylor F, Gross C, Rohde
K, McFall ME. A parallel group placebo controlled study
of prazosin for trauma nightmares and sleep disturbance in